ABL Bio Inc (298380) — Cash Flow Quality Index
Latest as of June 2025:
0.96x
ABL Bio Inc (298380) has a Cash Flow Quality Index of 0.96x as of June 2025. Operating cash flow of ₩38.30 Billion is below net income of ₩39.78 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore ABL Bio Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
0.96x
Operating CF / Net Income
Operating Cash Flow
₩38.30 Billion
KRW
Net Income
₩39.78 Billion
KRW
Data as of
Jun 2025
Most recent filing
ABL Bio Inc Cash Flow Quality Index (2022–2022)
Historical Cash Flow Quality Index for ABL Bio Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see ABL Bio Inc cash flow conversion.
Annual Cash Flow Quality Index for ABL Bio Inc (2022–2022)
Year-by-year earnings quality comparison for ABL Bio Inc.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 22.48x | ₩72.13 Billion | ₩3.21 Billion | — |
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.